Preferred Pharmaceuticals, Inc recalls Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count bottles
Recalled January 29, 2020 · FDA recall D-0796-2020 · Preferred Pharmaceuticals
Hazard
CGMP Deviations: Presence of NDMA impurity detected in product. · FDA Class II
Units
221,710 tablets
Sold at
Distribution to physicians in the following states: AL, AZ, CA, FL, GA, IN, and SC
Description
CGMP Deviations: Presence of NDMA impurity detected in product.
Product
Preferred Pharmaceuticals, Inc, Ranitidine Tablets, 150 mg, a) 30 count bottles (NDC: 68788-7388-3), b) 60 count bottles (NDC: 68788-7388-6), c) 90 count bottles (NDC: 68788-7388-9), d) 100 count bottles (NDC: 68788-7388-1)
Manufacturer(s)
Preferred Pharmaceuticals, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →